WILMINGTON, Del. - Eighteen states have sued Abbott Laboratories in federal court, alleging the drug maker blocked generic competition for a popular cholesterol medication, TriCor, state officials said Tuesday.
The antitrust lawsuit against Abbott and French drug company Fournier Industrie et Sante and Laboratories Fournier SA, charges the companies sought to block competition for a cheaper, generic version of the prescription drug TriCor.
The cholesterol drug accounted for more than $1 billion of Abbott's sales last year. The North Chicago, Ill.-based company had total revenue of $25.9 billion in 2007.
More news at Chicago Tribune
The Florida AG's website
tag: TRICOR, Fournier Industrie, Abbot Laboratories, Drug Companies, cholesterol medication,
No comments:
Post a Comment